Driven by Insights
Solve the complex
We are at the forefront of AI-driven antibody discovery, pioneering an innovative approach with our LENSai™ platform powered by HYFT® technology. LENSai uncovers key relationships and hidden characteristics of your antibodies earlier in the research process, providing actionable insights to support data-driven decisions. By streamlining decision-making, LENSai helps optimize R&D, improving efficiency and accelerating progress. Discover the impact of AI-powered insights on your antibody discovery with LENSai.
Expanding diversity to address complex challenges.
Antibody discovery designed for broader, more effective therapeutic solutions.
Take out the guesswork. Discover more insights and hidden characteristics faster.
Accelerate antibody discovery and development timelines by up to 300%
Traditional methodsAverage 3-6 years*
Traditional methods
Average 3-6 years*
Fusion of in vitro, in vivo, in silico servicesAverage 1-3 years*
Fusion of lab and AI services
Average 1-3 years*
*Average approximation of timeline advantage.Projects may vary.
*Average approximation of timeline advantage.
Projects may vary.
See it in action
Applications enhanced by a range of additional functional tools
NGS Data Processing
V-domain repertoire NGS analyses
- Quick and easy workflow
- Supported technologies: Short read, Illumina MiSeq and NovaSeq
- Rapid results
Input Formats:
- Paired-end reads: Non-UMI and UMI-barcoded single cell: 10X format
Assembled repertoire ready for further analysis into the diversity of your sample
Hit Expansion
- Add-on to Phage display, B-cell, and Hybridoma output
- Fast analysis of complete NGS repertoires
- Enhanced insights into diversity of your sample through multimodal feature extraction - sequence, structure and LLM embeddings
Multi-modal analyses to retrieve Ab sequences with characteristics similar to binders
Epitope Binning
- Early triaging
- Analyze >5,000 sequences
- Rapid results
- No need for physical materials
- Proven to match wet lab results
Predicted bins cluster antibodies with similar target binding regions. Triage candidates through an Interactive dashboard.
Epitope Mapping
- High-throughput
- No need for physical materials
- Integrated structural modeling capabilities
- All target types
- Get insights earlier in the discovery & development process
Insight in predicted epitope region and interacting antigen residues through an interactive dashboard.
Expand your discovery boundaries
No guesswork—just clear, actionable insights. Gain precise data points for every hit in your experiment, uncovering hidden candidates and enabling deeper analysis, smarter decision-making, and faster, more informed discoveries across your entire process.
LENSai Discovery
Innovate without limits: choose your path
Access to our cutting-edge technology is designed with flexibility in mind, offering multiple formats tailored to your unique requirements. Whether you’re seeking seamless integration, full-scale deployment, or a customized solution, we have an option to elevate your research.
BioIntelligence Suite Fee-for-Service
Customized solutions allowing clients to leverage expert capabilities and advanced technologies for their specific research needs.
BioIntelligence Cloud SaaS
Early access to LENSai SaaS model empowers users to leverage cutting-edge tools and features ahead of the competition, enhancing productivity and innovation.
Scalable API Access
API access streamlines integration, allowing seamless connection to powerful tools and data for enhanced research efficiency.
Strategic Partnership
Strategic partnerships in antibody discovery grant access to all technologies, accelerating innovation and driving shared success through combined expertise and resources.
Seamless continuum: merging wet lab power with LENSai for clinical breakthroughs
Unlock unparalleled efficiency and optimization with our customized end-to-end solution, seamlessly integrating in vitro, in vivo, and in silico through a combined fee-for-service or partnership offering with IPA (our parent company). This comprehensive strategy accelerates your decision-making and propels therapeutic approaches from discovery to the clinic faster than ever. Trusted by 19 of the top 20 pharma companies, our expertise and service depth offering is your key to achieving clinical success with precision and speed.
See IPAPowered by:
BioStrand proprietary data integration intelligence
LENSai platform is hosted on AWS
Vector search intelligence is at the core of LENSai platform, seamlessly integrated with the InterSystems IRIS data platform to deliver precise, scalable solutions that accelerate antibody discovery, enhance accuracy, and increase candidate diversity.